You just read:

Santaris Pharma A/S Obtains Exclusive License from Mass General Hospital for Intellectual Property Related to the Regulation of miR-33 for the Treatment of Cardiovascular Disorders

News provided by

Santaris Pharma A/S

28 Feb, 2011, 12:15 GMT